Market Cap: $36.13M
GI
Grace Therapeutics, Inc.
GRCE
NASDAQ (NASDAQ Global Market)USD
Market Cap: $36.13M
Analysts estimated GRCE earnings of $-0.23 per share this quarter (Q4). GRCE's actual earnings were $-0.06 per share.
GRCE EPS surprise of 74.42%Analysts estimated GRCE earnings of $-0.29 per share this quarter (Q3). GRCE's actual earnings were $-0.14 per share.
GRCE EPS surprise of 50.98%Analysts estimated GRCE earnings of $-0.19 per share this quarter (Q2). GRCE's actual earnings were $-0.06 per share.
GRCE EPS surprise of 68.20%Analysts estimated GRCE earnings of $-0.22 per share this quarter (Q1). GRCE's actual earnings were $-0.21 per share.
GRCE EPS surprise of 6.42%Analysts estimated GRCE earnings of $-0.32 per share this quarter (Q4). GRCE's actual earnings were $0.10 per share.
GRCE EPS surprise of 131.63%Analysts estimated GRCE earnings of $-0.44 per share this quarter (Q3). GRCE's actual earnings were $-0.26 per share.
GRCE EPS surprise of 40.72%